Applying imperfect treatments better, debating rationing, and abusing impact factorsBMJ 1997; 314 doi: https://doi.org/10.1136/bmj.314.7079.0 (Published 15 February 1997) Cite this as: BMJ 1997;314:0
John Swales, director of research and development in the National Health Service, asks us to imagine that we had a perfect treatment for hypertension (p 466). We could do much good with such a treatment, but we could do more, he reminds us, by making sure that everybody with hypertension was treated with our current imperfect treatments. That's a theme in this BMJ.
In Japan operative mortality with patients with gastric cancer is 2% and five year survival is 86% (p 467). Similar results can be achieved in Britain, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial